Codexis (CDXS) Competitors $2.43 -0.01 (-0.41%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.43 0.00 (0.00%) As of 09/12/2025 06:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CDXS vs. ZBIO, RIGL, VSTM, MYGN, XOMA, EBS, LXRX, CBIO, VNDA, and IRWDShould you be buying Codexis stock or one of its competitors? The main competitors of Codexis include Zenas BioPharma (ZBIO), Rigel Pharmaceuticals (RIGL), Verastem (VSTM), Myriad Genetics (MYGN), XOMA Royalty (XOMA), Emergent Biosolutions (EBS), Lexicon Pharmaceuticals (LXRX), Crescent Biopharma (CBIO), Vanda Pharmaceuticals (VNDA), and Ironwood Pharmaceuticals (IRWD). These companies are all part of the "biotechnology" industry. Codexis vs. Its Competitors Zenas BioPharma Rigel Pharmaceuticals Verastem Myriad Genetics XOMA Royalty Emergent Biosolutions Lexicon Pharmaceuticals Crescent Biopharma Vanda Pharmaceuticals Ironwood Pharmaceuticals Codexis (NASDAQ:CDXS) and Zenas BioPharma (NASDAQ:ZBIO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation. Does the media favor CDXS or ZBIO? In the previous week, Zenas BioPharma had 1 more articles in the media than Codexis. MarketBeat recorded 3 mentions for Zenas BioPharma and 2 mentions for Codexis. Codexis' average media sentiment score of 1.19 beat Zenas BioPharma's score of 1.04 indicating that Codexis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Codexis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zenas BioPharma 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings & valuation, CDXS or ZBIO? Codexis has higher revenue and earnings than Zenas BioPharma. Zenas BioPharma is trading at a lower price-to-earnings ratio than Codexis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCodexis$59.35M3.70-$65.28M-$0.83-2.93Zenas BioPharma$5M170.38-$156.99M-$3.55-5.70 Do analysts recommend CDXS or ZBIO? Codexis presently has a consensus price target of $11.00, indicating a potential upside of 352.67%. Zenas BioPharma has a consensus price target of $36.67, indicating a potential upside of 81.25%. Given Codexis' higher probable upside, equities analysts clearly believe Codexis is more favorable than Zenas BioPharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Codexis 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Zenas BioPharma 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CDXS or ZBIO more profitable? Zenas BioPharma has a net margin of 0.00% compared to Codexis' net margin of -113.67%. Zenas BioPharma's return on equity of -59.21% beat Codexis' return on equity.Company Net Margins Return on Equity Return on Assets Codexis-113.67% -105.83% -46.06% Zenas BioPharma N/A -59.21%-50.56% Do insiders & institutionals believe in CDXS or ZBIO? 78.5% of Codexis shares are held by institutional investors. 1.9% of Codexis shares are held by company insiders. Comparatively, 16.5% of Zenas BioPharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryCodexis beats Zenas BioPharma on 8 of the 15 factors compared between the two stocks. Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDXS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDXS vs. The Competition Export to ExcelMetricCodexisMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$219.36M$3.15B$5.78B$10.18BDividend YieldN/A2.32%5.73%4.60%P/E Ratio-2.9321.5775.4626.02Price / Sales3.70254.90464.4091.13Price / CashN/A44.4425.8129.91Price / Book2.969.6112.166.25Net Income-$65.28M-$53.29M$3.29B$270.76M7 Day Performance-0.82%0.57%0.73%2.54%1 Month Performance-19.27%4.56%4.41%5.73%1 Year Performance-12.59%10.44%62.61%25.85% Codexis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDXSCodexis3.3822 of 5 stars$2.43-0.4%$11.00+352.7%-12.6%$219.36M$59.35M-2.93250Positive NewsZBIOZenas BioPharma1.192 of 5 stars$21.51+4.9%$36.67+70.5%N/A$863.68M$5M-6.06N/AHigh Trading VolumeRIGLRigel Pharmaceuticals1.9142 of 5 stars$40.87-1.1%$38.20-6.5%+177.1%$741.53M$179.28M7.55160Positive NewsVSTMVerastem2.8593 of 5 stars$10.23-5.0%$13.29+29.9%+245.9%$662.84M$2.14M-3.1250Positive NewsAnalyst DowngradeMYGNMyriad Genetics3.706 of 5 stars$6.91+4.5%$12.45+80.2%-73.8%$615.03M$832.90M-1.612,700Positive NewsXOMAXOMA Royalty4.2016 of 5 stars$35.35+0.3%$69.50+96.6%+29.1%$425.97M$28.49M-22.8110Positive NewsEBSEmergent Biosolutions4.7589 of 5 stars$7.59+0.1%$14.33+88.9%+3.6%$404.40M$812.50M3.102,420Positive NewsLXRXLexicon Pharmaceuticals2.35 of 5 stars$1.08-0.9%$3.23+198.6%-32.4%$396.11M$31.08M-3.27140CBIOCrescent Biopharma4.397 of 5 stars$12.95-9.1%$25.60+97.7%N/A$278.39M$10K-0.3750VNDAVanda Pharmaceuticals4.0675 of 5 stars$4.55-1.3%$16.50+262.6%-11.6%$272.40M$198.77M-4.03290IRWDIronwood Pharmaceuticals4.1516 of 5 stars$1.13-2.2%$4.94+337.2%-71.3%$187.61M$351.41M-22.60220 Related Companies and Tools Related Companies ZBIO Alternatives RIGL Alternatives VSTM Alternatives MYGN Alternatives XOMA Alternatives EBS Alternatives LXRX Alternatives CBIO Alternatives VNDA Alternatives IRWD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDXS) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Codexis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Codexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDXS Stock Alerts